Kristina Burow
InvestorManaging Director at ARCH Venture Partners
United States
Writes $50K – $150M checks · typically $50K
FoundedAgbiomeAutobahn Therapeutics, Inc.Beam TherapeuticsBoragenBoundless BioGossamer Bio
About
Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Deals · 14
Autobahn Therapeutics, Inc.Board seat
via ARCH Venture Partners · filed Aug 2024 · $120M raise
Boundless BioBoard seat
via ARCH Venture Partners · filed May 2021 · $105.6M raise
Vividion TherapeuticsBoard seat
via ARCH Venture Partners · filed May 2019 · $82M raise
Beam TherapeuticsBoard seat
via ARCH Venture Partners · filed Mar 2019 · $83.6M raise
Vir BiotechnologyBoard seat
via ARCH Venture Partners · filed Jun 2018
Scholar Rock Holding Corp, Inc.Board seat
via ARCH Venture Partners · filed Jan 2018 · $47M raise
Sienna BiopharmaceuticalsBoard seat
via ARCH Venture Partners · filed May 2017 · $40.5M raise
TrelysBoard seat
via ARCH Venture Partners · filed Apr 2017 · $80K raise
BoragenBoard seat
via ARCH Venture Partners · filed Mar 2017 · $10.5M raise
MetacrineBoard seat
via ARCH Venture Partners · filed Nov 2016 · $37.8M raise
Scholar RockBoard seat
via ARCH Venture Partners · filed Jan 2016 · $40M raise
AgbiomeBoard seat
via ARCH Venture Partners · filed Aug 2015 · $34.5M raise
LyceraBoard seat
via ARCH Venture Partners · filed Jun 2015
ErascaQuoted
via ARCH Venture Partners · filed Apr 2020
Attribution from SEC filings, press coverage, and firm rosters.
